Altimmune to participate at two upcoming investor conferences

Gaithersburg, md., nov. 22, 2022 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the company's management team will participate at the following investor conferences:
ALT Ratings Summary
ALT Quant Ranking